Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects

Clinical and Experimental Allergy

Volumn 26, Issue 2, 1996, Pages 202-215

  Taylor, M L ^a   Misso, N L A ^a   Stewart, G A ^b   Thompson, P J ^a  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Arachidonic acid; Aspirin sensitive asthma; CD62P; CD63; Collagen; Platelet activating factor; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CD63 ANTIGEN; COLLAGEN; PADGEM PROTEIN; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; ARACHIDONIC ACID; ASPIRIN; ASTHMA; BLOOD PLATELETS; CELL ADHESION MOLECULES; COLLAGEN; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATING FACTOR; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS;

EID: 0030024161     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00081.x     Document Type: Article

References (45)

1. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsy in asthma: an ultrastructural quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140:1745-53.
2. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
3. Metzger WJ, Sjoervdsma K, Richerson HB. Platelets in bronchoalveolar lavage from asthmatic patients and allergic rabbits with allergen-induced late phase responses. Agents Actions 1987; 21 (Suppl):151-9.
4. Capron A, Joseph M, Ameisen JC, Tonnel AB. From parasites to allergy: a second receptor for IgE. Immunol Today 1986; 7:15-8.
5. Ind PW. Platelet and clotting abnormalities in asthma. Clin Exp Allergy 1991; 21:395-8.
6. Taytard A, Guenard H, Vuillemin L et al. Platelet kinetics in stable atopic asthmatic patients. Am Rev Respir Dis 1986; 134:983-5.
7. Szczeklik A, Milner PC, Birch J, Watkins J, Martin JF. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb Haemost 1986; 56:283-7.
8. Yamamoto H, Nagata M, Tabe K et al. The evidence of platelet activation in bronchial asthma. J Allergy Clin Immunol 1993; 91:79-87.
9. Knauer KA, Lichtenstein LM, Adkinson NF, Fish JE. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med 1981; 304:1404-7.
10. Durham SR, Dawes J, Kay AB. Platelets in asthma. Lancet 1985; 2:36.
11. Gresele P, Dottorini M, Selli ML et al. Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma. J Allergy Clin Immunol 1993; 91:894-902.
12. Averill FJ, Hubbard WC, Proud D, Gleich GJ, Liu MC. Platelet activation in the lung after antigen challenge in a model of allergic asthma. Am Rev Respir Dis 1992; 145:571-6.
13. Ameisen JC, Capron A, Joseph M et al. Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Int Arch Allergy Appl Immunol 1985; 78:438-48.
14. Pearson DJ, Suarez-Mendez VJ. Abnormal platelet hydrogen peroxide metabolism in aspirin-sensitivity. Clin Exp Allergy 1990; 20:157-63.
15. Williams RW, Pawlowicz A, Davies BH. In vitro tests for the diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1990; 86:445-51.
16. Pearson DJ, Suarez-Mendez VJ, Day JP, Miller PF. Selenium status in relation to reduced glutathione peroxidase activity in aspirin-sensitive asthma. Clin Exp Allergy 1991; 21:203-8.
17. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70:307-15.
18. Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65:467-73.
19. Corash L. Measurement of platelet activation by fluorescence-activated flow cytometry. Blood Cells 1990; 16:97-108.
20. Metzelaar MJ, Sixma JJ, Niewenhuis HK. Detection of platelet activation using activation specific monoclonal antibodies. Blood Cells 1990; 16:85-96.
21. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101:880-6.
22. Berman CL, Yeo EL, Wencel-Drake JD et al. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986; 78:130-7.
23. McEver RP. GMP-140: A receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991; 45:156-61.
24. Metzelaar MJ, Schuurman H, Heijnen H, Sixma JJ, Niewenhuis HK. Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies. Virchows Archiv B Cell Pathol 1991; 61:269-77.
25. Vischer U, Wagner DD. CD63 is a component of Weibelpalade bodies of human endothelial cells. Blood 1993; 82:1184-91.
26. Niewenhuis HK, van Oosterhout JJG, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70:838-45.
27. Metzelaar MJ, Clevers HC. Lysosomal membrane glycoproteins in platelets. Thromb Haemost 1992; 68: 378-82.
28. Taylor ML, Misso NLA, Stewart GA, Thompson PJ. Differential expression of platelet activation markers CD62 and CD63 following stimulation with PAF, arachidonic acid and collagen. Platelets, in press.
29. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315:983-9.
30. George JN, Pickett EB, Saucerman S et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 40:340-8.
31. Taylor ML, Stewart GA, Thompson PJ. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. Br J Clin Pharmacol 1993; 35:227-34.
32. Taylor ML, Misso NLA, Stewart GA, Thompson PJ. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid. Br J Clin Pharmacol 1992; 33:25-31.
33. Del Maschio A, Dejana E, Bazzoni G. Bidirectional modulation of platelet and polymorphonuclear leukocyte activities. Ann Hematol 1993; 67:23-31.
34. Thompson PJ, Hanson JM, Bilani H, Turner-Warwick M, Morley J. Platelets, platelet-activating factor and asthma. Am Rev Respir Dis 1984; 129(Suppl):A3.
35. Misso NLA, Gillon RL, Taylor ML, Stewart GA, Thompson PJ. Acetyl-CoA: lyso-platelet-activating factor acetyltransferase activity in neutrophils from asthmatic patients and normal subjects. Clin Sci 1993; 85:455-63.
36. Kroegel C, Virchow JC, Kortsik C, Matthys H. Cytokines, platelet activating factor and eosinophils in asthma. Respir Med 1992; 86:375-89.
37. Hsieh KH, Ng CK. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol 1993; 91:650-7.
38. Chronos NAF, Wilson DJ, Janes SL et al. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of α-granules or lysosomes from, human platelets. Clin Sci 1994; 87:575-80.
39. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine-diphosphate-induced platelet α-granule release. Blood 1993; 82:505-12.
40. Christie PE, Smith C, Arm JP, Lee TH. Aspirin-sensitive asthma. Clin Exp Allergy 1992; 22:171-5.
41. Holtzman MJ, Turk J, Shornick LP. Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J Biol Chem 1992; 267:21438-45.
42. Meade EA, Smith WL, De Witt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268:6610-4.
43. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143:1025-9.
44. 4 in bronchial asthma. Eur Respir J 1992; 5:693-9.
45. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15:7-10.